UnitedHealth Group Incorporated Investor Alert (NYSE: UNH): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors Following DOJ Probe and for Possible False Statements

Core Viewpoint - UnitedHealth Group is under criminal investigation for fraud and has suspended its fiscal guidance for 2025, leading to significant stock price decline and potential legal claims from investors [1][2]. Group 1: Legal Investigations - UnitedHealth is facing a criminal investigation by the U.S. Department of Justice (DOJ) related to its Medicare Advantage program [2]. - The company is also subject to a civil investigation by the DOJ concerning its Medicare billing practices [2]. - An antitrust investigation is ongoing regarding UnitedHealth's Optum health services division [2]. - A class action lawsuit has been filed against UnitedHealth in the U.S. District Court for the District of Minnesota [2][3]. Group 2: Management Changes - CEO Andrew Witty resigned on May 13, 2025, citing "personal reasons," coinciding with the suspension of the company's fiscal guidance for 2025 [2]. Group 3: Financial Impact - UnitedHealth's stock price has decreased by approximately 50% since April 2025 due to the revelations of the investigations, resulting in substantial losses for shareholders [2].